Sze, G <br/><br/>
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.  [electronic resource] 

 -  Investigative radiology  Mar 1993 
 - S49-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0020-9996 
<br/><br/><label>Standard No.: </label>10.1097/00004424-199303001-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Central Nervous System Diseases--diagnosis<br/>Contrast Media--toxicity<br/>Female<br/>Gadolinium--toxicity<br/>Gadolinium DTPA<br/>Humans<br/>Injections, Intravenous<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Organometallic Compounds--toxicity<br/>Pentetic Acid--toxicity